Boston Partners’s Aspen Aerogels ASPN Stock Holding History
Bought
Maintained
Sold
Other funds holding ASPN
GKFF
OCMI
TAM
NIM
RA
NCGI
DCM
Boston Partners's ASPN Position: Q4 2020 in Review
Boston Partners sold out of Aspen Aerogels (ASPN) in Q4 2020, closing a stake of 71,984 shares — an estimated $788K sold.
Boston Partners first reported a position in ASPN in Q2 2019 and held it in 6 quarters. The position peaked at $1.57M in Q4 2019. 76 funds tracked by Wall St. Rank hold ASPN as of Q4 2020.
- Boston Partners reported no remaining Aspen Aerogels position as of Q4 2020 after selling out during the quarter.
- Boston Partners sold 71,984 Aspen Aerogels shares in Q4 2020, an estimated $788K.
- Boston Partners first reported a position in Aspen Aerogels in Q2 2019 and held it in 6 quarters.
- Boston Partners's Aspen Aerogels position peaked at $1.57M in Q4 2019.
- 76 funds tracked by Wall St. Rank held Aspen Aerogels as of Q4 2020.
Based on Boston Partners's 13F filing for Q4 2020, filed 4 Feb 2021.